Stock Analysis on Net

Celgene Corp. (NASDAQ:CELG)

This company has been moved to the archive! The financial data has not been updated since October 31, 2019.

Common-Size Balance Sheet: Liabilities and Stockholders’ Equity 

Celgene Corp., common-size consolidated balance sheet: liabilities and stockholders’ equity

Microsoft Excel
Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014
Short-term borrowings and current portion of long-term debt 1.41 0.00 1.78 0.00 3.49
Accounts payable 1.18 1.01 0.88 0.89 1.14
Rebates, distributor chargebacks and distributor services 3.12 2.70 2.00 1.36 1.34
Compensation 1.10 1.19 1.47 1.31 1.83
Clinical trial costs and grants 1.34 2.06 1.22 0.94 1.09
Litigation-related loss contingency 0.00 0.00 0.71 0.00 0.00
Interest 0.67 0.57 0.60 0.63 0.34
Sales, use, value added, and other taxes 0.19 0.20 0.36 0.26 0.38
Milestones payable 0.00 0.21 0.00 0.00 0.00
Success payment liability 0.20 0.00 0.00 0.00 0.00
Short-term contingent consideration and success payments 0.17 0.00 0.17 0.40 0.20
Royalties, license fees and collaboration agreements 0.32 0.17 0.00 0.00 0.00
Deferred tax liability 0.00 0.00 0.00 0.00 0.76
Other 1.31 1.27 1.01 1.20 1.36
Accrued expenses and other current liabilities 8.42% 8.37% 7.53% 6.09% 7.31%
Income taxes payable 0.22 0.28 0.15 0.07 0.07
Current portion of deferred revenue 0.21 0.25 0.20 0.22 0.16
Current liabilities 11.43% 9.91% 10.54% 7.28% 12.18%
Deferred revenue, net of current portion 0.21 0.11 0.10 0.11 0.16
Income taxes payable 6.17 8.26 1.50 1.20 1.57
Deferred income tax liabilities 7.76 4.40 0.00 1.40 3.20
Other non-current tax liabilities 0.00 0.00 8.97 9.31 0.00
Contingent consideration 0.29 0.27 5.14 5.22 7.18
Deferred compensation and long-term incentives 0.68 0.80 0.77 0.63 0.87
Contingent value rights 0.05 0.14 0.16 0.19 0.79
Derivative contracts 0.06 0.44 0.00 0.00 0.00
Other 0.26 0.16 0.24 0.11 0.29
Other non-current liabilities 1.34% 1.80% 6.31% 6.15% 9.12%
Long-term debt, net of discount, excluding current portion 55.72 52.55 49.09 52.68 36.13
Non-current liabilities 71.20% 67.13% 65.97% 70.84% 50.19%
Total liabilities 82.64% 77.04% 76.50% 78.12% 62.37%
Preferred stock, $.01 par value per share; none outstanding 0.00 0.00 0.00 0.00 0.00
Common stock, $.01 par value per share 0.03 0.03 0.03 0.03 0.05
Common stock in treasury, at cost -74.23 -67.16 -57.97 -51.94 -61.70
Additional paid-in capital 42.22 45.80 44.07 41.10 56.67
Retained earnings 49.49 43.33 35.87 29.85 37.33
Accumulated other comprehensive income (loss) -0.14 0.95 1.49 2.84 5.28
Stockholders’ equity 17.36% 22.96% 23.50% 21.88% 37.63%
Total liabilities and stockholders’ equity 100.00% 100.00% 100.00% 100.00% 100.00%

Based on: 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31).

Balance sheet item Description The company
Current liabilities Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. Celgene Corp. current liabilities as a percentage of total liabilities and stockholders’ equity decreased from 2016 to 2017 but then increased from 2017 to 2018 exceeding 2016 level.
Non-current liabilities Amount of obligation due after one year or beyond the normal operating cycle, if longer. Celgene Corp. non-current liabilities as a percentage of total liabilities and stockholders’ equity increased from 2016 to 2017 and from 2017 to 2018.
Total liabilities Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future. Celgene Corp. total liabilities as a percentage of total liabilities and stockholders’ equity increased from 2016 to 2017 and from 2017 to 2018.
Stockholders’ equity Total of all stockholders’ equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity stockholders’ equity attributable to the parent excludes the amount of stockholders’ equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity. Celgene Corp. stockholders’ equity as a percentage of total liabilities and stockholders’ equity decreased from 2016 to 2017 and from 2017 to 2018.